← Back to results

Executive Director, Asset Team Lead

Lead strategic asset positioning for small molecule clinical programs in oncology and immunology at Recursion Pharmaceuticals.

Location
United States
Compensation
Not disclosed
Level
director
Type
full time · Remote

Posted by employer 2 days ago

First seen on Joblaze 16 hours ago

Last verified on the company career page 16 hours ago

What you'll build

  • Define and drive asset strategy for small molecule clinical programs
  • Translate Recursion OS and ClinTech insights into strategic asset advantages
  • Develop and pressure-test the competitive narrative for each portfolio asset
  • Partner with functional line leaders to ensure resource allocation reflects strategic conviction
  • Propagate the Recursion mindset of radically changing lives

Must have

  • PhD in life sciences or related scientific discipline
  • 10+ years of biotech/pharma experience
  • Deep expertise in the development of small molecule therapeutics for oncology and immunology/inflammation

Nice to have

  • Expertise in rare disease

AI in the day-to-day

Recursion OS is an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development.

Requirements

Experience
10+ years
Education
PhD

Not disclosed in this posting: compensation, visa sponsorship.

Benefits

Equity/Stock Options Remote Work

Joblaze summary

The Executive Director, Asset Team Lead at Recursion Pharmaceuticals is responsible for shaping the strategic direction of small molecule clinical programs in oncology and immunology, ensuring that decisions are informed by competitive insights and proprietary data. This role requires a strong background in drug discovery, particularly in small molecules, along with expertise in leveraging computational approaches for asset strategy. Ideal candidates will have over a decade of experience in biotech or pharma, with a proven track record in advancing clinical programs. The position involves collaboration across various teams, emphasizing a commitment to transforming drug development processes.

Joblaze insights

  • Listed today — first seen on Joblaze September 23, 2026. Last confirmed on Recursion Pharmaceuticals's careers page September 23, 2026.
  • This exact title is also open at 1 other location at Recursion Pharmaceuticals: Remote Opportunity - United States.

Quick facts

Is the Executive Director, Asset Team Lead role remote?
Yes — Recursion Pharmaceuticals lists this as a fully remote position.
How much experience is required?
At least 10 years of relevant experience for this Executive Director, Asset Team Lead role.
What seniority level is this role?
Recursion Pharmaceuticals targets director candidates for this position.
Is this full-time or contract?
Full-time for this Executive Director, Asset Team Lead role at Recursion Pharmaceuticals.

From the original posting

Your work will change lives. Including your own.

The Impact You’ll Make

As the Recursion clinical asset pipeline continues to mature through key inflection points, the advancing assets require leaders who can translate scientific complexity into strategic clarity. In the role of Executive Director, Asset Team Lead, you will drive the strategic positioning of assets, ensuring that decisioning is grounded in competitive reality, differentiated by Recursion OS insights, and built to move with urgency for patient benefit. You will play a pivotal role ensuring advanced computational approaches and proprietary Recursion OS/ClinTech advantages are leveraged across the portfolio continuum, redefining traditional paradigms of drug development. Working across functional lines, you will partner with preclinical, clinical and platform teams, promoting communication, alignment and optimization of functional processes to ensure delivery of portfolio goals & transformative medicines for patients.

In this role, you will:

  • Define and drive asset strategy for small molecule clinical programs in oncology and immunology/inflammation — integrating competitive positioning, mechanistic differentiation, biomarker strategy, and patient segmentation to sharpen go/no-go and prioritization decisions across the portfolio
  • Translate Recursion OS and ClinTech insights into strategic asset advantages, ensuring proprietary data and computational insights are maximally enabling for advancement of the drug discovery and development portfolio
  • Develop and pressure-test the competitive narrative for each oncology and I&I portfolio asset, building the evidence base that will inform leadership decisions, partnering discussions and investor communications
  • Partner with functional line leaders across clinical development, BD, finance and platform teams to ensure resource allocation reflects strategic conviction and supports the most impactful programs and workstreams
  • Propagate the Recursion mindset of radically changing lives by continuously raising the bar on how assets are advanced, differentiated, and delivered to patients with significant unmet need

The Team You’ll Join

As an Executive Director, Asset Team Lead, you will work across the asset portfolio, operating as a senior strategic partner to leaders in Clinical Development, Discovery, ClinTech, Platform and BD. The Portfolio Team is execution-minded and analytically rigorous — fluent in both science and AI — and responsible for industrializing Recursion's innovative science to advance medicines that matter. We break traditional silos, leveraging AI-powered platforms across data analysis, predictive modeling, RWE integration and patient stratification, all with the goal of optimizing asset positioning for the greatest benefit to patients.

The Experience You’ll Need

  • A PhD in life sciences or related scientific discipline with deep expertise in drug discovery & development required
  • 10+ years of biotech/pharma experience with a proven track record of asset-level strategic leadership, advancing programs through clinical stage-gates with demonstrable impact on portfolio value
  • Deep expertise in the development of small molecule therapeutics for oncology and immunology/inflammation required, expertise in rare disease a bonus
  • Experience leveraging computational approaches and data-driven platforms to sharpen asset strategy and clinical decision-making
  • Proven ability to build and articulate the strategic and competitive case for clinical assets – integrating mechanistic differentiation, competitive dynamics, regulatory and market considerations.
  • Strong financial acumen; able to engage credibly on cross-functional resourcing, asset valuation, and portfolio trade-offs
  • Exceptional executive presence – able to synthesize complexity into clear, conviction-led recommendations and present with confidence to senior leadership and external partners

Working Location & Compensation:

This is a remote position based in the United States with required periodic travel. In addition to base salary, this role is eligible for an annual bonus, equity compensation, and a comprehensive benefits package.

#LI-EP1

#LI-REMOTE

The Values We Hope You Share:

Standard company text repeated across Recursion Pharmaceuticals's postings is omitted here.

Similar positions

Recursion Pharmaceuticals
Executive Director, Asset Team Lead
Recursion Pharmaceuticals · Remote Opportunity - United States
Recursion Pharmaceuticals
Executive Director, Corporate Strategy & Intelligence
Recursion Pharmaceuticals · New York, New York
Recursion Pharmaceuticals
Associate Director, Computational Biology – Early Discovery
Recursion Pharmaceuticals · Salt Lake City, Utah
Recursion Pharmaceuticals
Vice President, Business Development and Licensing
Recursion Pharmaceuticals · New York, New York
Recursion Pharmaceuticals
Director, Clinical Pharmacology
Recursion Pharmaceuticals · London, England